The solid progress of nanomedicine
Peer reviewed, Journal article
MetadataShow full item record
Original versionDrug Delivery and Translational Research. 2020, 10 726-729. 10.1007/s13346-020-00743-2
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.